XML 17 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Cash Flow Statements - USD ($)
 3 Months Ended
Apr. 02, 2017
Apr. 03, 2016
Cash flows from operating activities:    
Net loss $ (3,308,000) $ (5,099,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,016,000 1,953,000
Stock-based compensation expense 175,000 363,000
Deferred loan costs recognized 15,000 205,000
Gain on the sale of assets (2,416,000) (2,370,000)
Provision for excess and obsolete inventory 35,000 25,000
Other noncash items 507,000 137,000
Changes in operating assets and liabilities:    
Accounts receivable (1,041,000) (1,066,000)
Inventory (5,027,000) (630,000)
Other current assets 413,000 423,000
Accounts payable 5,729,000 (1,048,000)
Accrued and other liabilities 3,062,000 2,397,000
Net cash used in operating activities (840,000) (4,710,000)
Cash flows from investing activities:    
Capital expenditures, net (176,000) (40,000)
Proceeds from sale of assets 2,502,000 11,066,000
Change in restricted cash 0 (6,000,000)
Net cash provided by investing activities 2,326,000 5,026,000
Cash flows from financing activities:    
Capital lease payments (37,000) 0
Principal payments on Term Loan 0 (429,000)
Proceeds from related party note payable 0 1,000,000
Net change in debt under New Revolving Credit Agreement 0 449,000
Debt issuance and modification costs 0 (379,000)
Indirect repurchase of shares of minimum statutory tax withholdings (2,000) 0
Net cash (used in) provided by financing activities (39,000) 641,000
Net increase in cash and cash equivalents 1,447,000 957,000
Cash and cash equivalents at beginning of period 15,270,000 1,349,000
Cash and cash equivalents at end of period $ 16,717,000 $ 2,306,000